Danny's inspiring survival story
30 May 2020
Danny Strosberg started to feel something was wrong when he noticed constant dizziness, daily headaches, and started to lose his vocabulary.
That’s when a CT scan revealed an egg-sized melanoma in his brain.
Danny underwent surgery to remove the tumour followed by six months of treatment. After a number of other tumours appeared throughout his body, he was placed on an immunotherapy clinical trial. It proved to be life saving.
Thanks to generous supporters, melanoma research has come so far. But we still have a long way to go. Our focus remains on achieving zero deaths from melanoma - a goal we believe we can reach in our lifetime.
“I had a complete response within about six months. All of my tumours disappeared.” Danny
Danny proudly calls himself a melanoma survivor. More than ever, he appreciates life, his friends and loved ones. He loves surfing and spending precious time with his wife Lisa and teenage daughter Gabby.
For patients like Danny, whose melanoma has spread to organs like their brain or lungs, clinical trials of new treatments are giving them a second chance at life.
Any life lost to melanoma is one too many. With your support, we will continue our research effort until we achieve our mission of zero deaths from melanoma.
Danny appreciates how immunotherapy treatment saved his life. Now he wants to give other patients the hope to watch their families grow up.
“The advances in melanoma research are being translated to other cancers, and the potential benefits are limitless. I literally owe my life to the work that is being done at MIA.” Danny
We hope Danny’s story inspires you to consider sending a donation.
Your gift could help fund a game-changing new treatment so that – one day very soon – no-one will die from melanoma.
Click below to donate securely via credit card, PayPal or direct deposit. Gifts over $2 are tax-deductible.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.